Approval Probability
TA Base Rate
Adjusted LOA
ML Risk
Alprazolam · 3 trials · 1 indication
| Arm | Type | Description |
|---|---|---|
| 1 | EXPERIMENTAL | Alprazolam Extended-Release Tablets 1 mg |
| 2 | ACTIVE_COMPARATOR | Xanax XR Tablets 1 mg |
| Name | Type | Description |
|---|---|---|
| Alprazolam Extended-Release Tablets 1 mg | DRUG | - |
| Xanax XR Tablets 1 mg | DRUG | - |
| Alprazolam Extended-Release Tablets 3 mg | DRUG | 3mg, single dose fasting |
| Xanax XR® Tablets (3 mg | DRUG | 3mg, single dose fasting |
| Xanax XR® Tablets 3 mg | DRUG | 3mg, single dose fed |
Inclusion Criteria: * 1\. Age: 18 years and older. 2. Sex: Male and/or non-pregnant, non-lactating female. 1. Women of childbearing potential must have negative serum beta human chorionic gonadotropin (beta-HCG) pregnancy tests performed within 14 days prior to the start of the study and on the ...